Letter by Li et al Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling"

Circulation. 2017 Nov 21;136(21):2092-2093. doi: 10.1161/CIRCULATIONAHA.117.029716.

Authors

Yangxin Li¹, Bin Liu², Chun Liang³

Affiliations

¹ Department of Cardiovascular Surgery, Institute for Cardiovascular Science, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China (Y.L.).
² Department of Cardiology, the Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China (B.L.).
³ Department of Cardiology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China (C.L.).

PMID: 29158220
DOI: 10.1161/CIRCULATIONAHA.117.029716

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Activating Transcription Factor 3*
Fibroblasts
Heart
Heart Failure*
Humans
MAP Kinase Kinase 3
Signal Transduction

Substances

Activating Transcription Factor 3
MAP Kinase Kinase 3
MAP2K3 protein, human